Keri A. Streby

Keri A. Streby's research focuses on treating high-risk and relapsed neuroblastoma, a childhood cancer of the nervous system, including immunotherapy approaches like dinutuximab (an antibody-based treatment) and experimental virus-based therapies. Work also includes multi-institutional clinical studies examining treatment outcomes, side effects, and supportive care (such as pain management and hormone-related complications) for pediatric patients undergoing intensive cancer treatment.

Publication activity has grown over the last decade, rising from sporadic output earlier on to a notable increase in output since 2022.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026